Cargando…

Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer

SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) represents a potential novel treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is based on the conjugation of photoactivating chemicals to cancer cell-specific antibodies. Antibody-photoabsorber-conjuga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Daisuke, Suzuki, Hidenori, Beppu, Shintaro, Terada, Hoshino, Sawabe, Michi, Hanai, Nobuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688155/ https://www.ncbi.nlm.nih.gov/pubmed/36428754 http://dx.doi.org/10.3390/cancers14225662

Ejemplares similares

Lymph Node Ratio in Head and Neck Cancer with Submental Flap Reconstruction
por: Suzuki, Hidenori, et al.
Publicado: (2022)

Total lesion glycolysis as a predictor of clinical T3–4a laryngeal cancer with laryngectomy or nonlaryngectomy
por: Suzuki, Hidenori, et al.
Publicado: (2021)

Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2020)

Lymph node ratio as a predictor for minor salivary gland cancer in head and neck
por: Suzuki, Hidenori, et al.
Publicado: (2021)

Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma
por: Suzuki, Hidenori, et al.
Publicado: (2022)

Safety and Efficacy of Salvage Neck Dissection Following Carbon-ion Radiotherapy with Chemotherapy for a Patient with Mucosal Malignant Melanoma of Head and Neck
por: Suzuki, Hidenori, et al.
Publicado: (2020)

Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma
por: Hagiwara, Sumitaka, et al.
Publicado: (2021)

Association between treatment package time and clinical predictors in oropharyngeal cancer
por: Suzuki, Hidenori, et al.
Publicado: (2020)

Near-Infrared Photoimmunotherapy of Cancer
por: Kobayashi, Hisataka, et al.
Publicado: (2019)

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Near infrared photoimmunotherapy for cancers: A translational perspective
por: Maruoka, Yasuhiro, et al.
Publicado: (2021)

Near infrared photoimmunotherapy of cancer; possible clinical applications
por: Wakiyama, Hiroaki, et al.
Publicado: (2021)

Expanding the application of cancer near-infrared photoimmunotherapy
por: Kobayashi, Hisataka
Publicado: (2021)

Near‐infrared photoimmunotherapy through bone
por: Nakamura, Yu A., et al.
Publicado: (2019)

Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective
por: Matsuoka, Kohei, et al.
Publicado: (2022)

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy
por: Kato, Takuya, et al.
Publicado: (2021)

Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2018)

Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond
por: Wei, Danfeng, et al.
Publicado: (2022)

Near infrared photoimmunotherapy with an anti-mesothelin antibody
por: Nagaya, Tadanobu, et al.
Publicado: (2016)

Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage
por: Suzuki, Hidenori, et al.
Publicado: (2018)

Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
por: Furumoto, Hideyuki, et al.
Publicado: (2022)

Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy
por: Mohiuddin, T. M., et al.
Publicado: (2023)

PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model
por: Jin, Jiefu, et al.
Publicado: (2022)

Trastuzumab‐based near‐infrared photoimmunotherapy in xenograft mouse of breast cancer
por: Yamashita, Susumu, et al.
Publicado: (2022)

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
por: Okada, Ryuhei, et al.
Publicado: (2021)

Near-infrared photoimmunotherapy: a comparison of light dosing schedules
por: Ogata, Fusa, et al.
Publicado: (2017)

In Vitro Comparative Study of Near-Infrared Photoimmunotherapy and Photodynamic Therapy
por: Yamashita, Susumu, et al.
Publicado: (2023)

Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model
por: Sato, Kazuhide, et al.
Publicado: (2015)

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer
por: Isobe, Yoshitaka, et al.
Publicado: (2020)

Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers
por: Cui, Yingshu, et al.
Publicado: (2023)

Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
por: Furumoto, Hideyuki, et al.
Publicado: (2022)

Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience
por: Sato, Kazuhide, et al.
Publicado: (2015)

Contrast-enhanced ultrasound imaging for monitoring the efficacy of near-infrared photoimmunotherapy
por: Matsuoka, Kohei, et al.
Publicado: (2023)

Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer
por: Yamaguchi, Haruka, et al.
Publicado: (2019)

Recurrent ameloblastoma with both hypercalcemia and BRAF mutation: A case report
por: Suzuki, Hidenori, et al.
Publicado: (2020)

Quickly evolving near-infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment
por: Monaco, Hailey, et al.
Publicado: (2022)

Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules
por: Mitsunaga, Makoto, et al.
Publicado: (2011)

Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy
por: Mitsunaga, Makoto, et al.
Publicado: (2012)

Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models
por: Hollandsworth, Hannah M., et al.
Publicado: (2020)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f44fnt81bf0s0p68s1rranu17b